Notably, patient clustering by these biomarkers in combination with cytoplasmic Kaiso expression identifies multiple breast cancer groups (A1-C2) with distinct survival differences (Fig. 3b and Supplementary Fig. 5). Here, ZBTB33 is linked to breast cancer.